Anhydrous Trisodium
- Plant preparation
- Varies by country
- Identity checked
- Sources last checked 2026-09-04
This page shows what was measured, who it was measured in, and what that does not settle.
RNAWiki holds very little about this substance. The page shows what there is.
What Anhydrous Trisodium does in the body
SODIUM CITRATE 4% W/V ANTICOAGULANT SOLUTION is intended for use only for the anticoagulation of whole blood as part of automated apheresis procedures. ] SODIUM CITRATE 4% W/V ANTICOAGULANT SOLUTION USP is intended for use only for the anticoagulation of whole blood as part of automated apheresis procedures.
SODIUM CITRATE 4% W/V ANTICOAGULANT SOLUTION USP acts as an extracorporeal anticoagulant by binding the free calcium in the blood. Calcium is a necessary co-factor to several steps in the clotting cascade. The following ingredients are key components of the solution: Citric acid for pH regulation Sodium Citrate anticoagulant This solution has no pharmacological effect.
Why people take it. SODIUM CITRATE 4% W/V ANTICOAGULANT SOLUTION is intended for use only for the anticoagulation of whole blood as part of automated apheresis procedures. [See Dosage and Administration (2) .] SODIUM CITRATE 4% W/V ANTICOAGULANT SOLUTION USP is intended for use only for the anticoagulation of whole blood as part of automated apheresis procedures.
What happened in people
RNAWiki has not yet published a reviewed conclusion for this use.
A fixed RNAWiki sentence
Where this came from
Wording RNAWiki always uses, not a finding about this substance.
No reviewed claim names a result for any goal on this record.
No source is stored against this line.
The limit that matters most
Not recorded.
- Where it acts
- Not recorded.
- Kind of result
- No result is published, so no kind of result applies yet
- Supervision
- Not usually supervised: sold as a supplement or food ingredient where recorded. That is a legal category, not a safety judgement.
What the registries record it as
The supplement label database classes it as other, under the name Sodium Citrate.
NIH Dietary Supplement Label Database · 2694 · read 2026-08-29
Where each sentence above came from
The use the label states, quoted from it. No plain-language version of this sentence has been written.
The use the label states, quoted from it. It is written for a clinician, not for a reader without medical training.
No statement of the main limit is recorded.
The four opening statements run to 170 words.
Words this page uses
Four words worth knowing first
Chosen from what this page shows, with each one explained before the word it depends on.
Biomarker
A biomarker is a number from a test that stands in for something about health.
A picture of it, and where the picture fails
A biomarker is like a fuel gauge.
Where that stops being true. A gauge is wired to the tank. Many biomarkers are only loosely tied to health.
What people get wrong. A better number is read as a better life. Several medicines improved a number and helped nobody.
A measurable indicator used as a substitute for a clinical outcome of interest.
Placebo
A placebo is a dummy treatment given so the real one can be compared with it.
A picture of it, and where the picture fails
A placebo is like a blank control in an experiment.
Where that stops being true. A blank does nothing. People given a placebo often do get better.
What people get wrong. A placebo effect is read as imaginary. The improvement is measured and real.
An inactive intervention matched in appearance to the test intervention, used to control for non-specific effects.
Comparator
A comparator is whatever the treatment was measured against.
A picture of it, and where the picture fails
It is like the other runner in a race.
Where that stops being true. A race has one winner. A study can show both arms improved.
What people get wrong. Results are read without asking what the other group got. Beating nothing is not beating a treatment.
The control condition against which the experimental intervention is assessed.
What happened in peopleRead from sources, not yet reviewed
What was measured, goal by goal
One row for each goal a registered study measured something for. One column for each kind of thing that could be measured.
Registered studies list 16 outcome measures that RNAWiki could read. A registered study says what someone planned to measure. It does not say what they found. 0 of the matched studies tested this substance, and 0 posted a result.
There is no single score. A strong test result and a weak life result are different facts.
| Goal | Life outcome | What a body can do | How a person feels | A test result | A step in the body | Harms | How long | Who was studied |
|---|---|---|---|---|---|---|---|---|
| Healthy ageing | Waiting for a reviewer2 registered study measure of this kind. No reviewed result yet. | Nothing in the sources checkedNo registered study lists a performance measure for this goal. | Nothing in the sources checkedNo registered study lists a symptom measure for this goal. | Nothing in the sources checkedNo registered study lists a test result for this goal. | Nothing in the sources checkedNo registered study lists a body-step measure for this goal. | Not recordedHarms were not a registered measure for this goal. | Not recordedNo finished study window is recorded. | Waiting for a reviewerWho was studied is listed further down the page. |
Which registered measures put each goal on this table
- Healthy ageing
- mortality; all cause mortality
Sorted by fixed word lists, version v1. A name the rules do not recognise stays unsorted rather than moving to the nearest column.
What each mark on this table means
- Waiting for a reviewer
- 2 registered study measure of this kind. No reviewed result yet.
- Nothing in the sources checked
- No registered study lists a performance measure for this goal.
- Not recorded
- Harms were not a registered measure for this goal.
What happened in peopleRead from sources, not yet reviewed
How close this is to real life
The top step is something a person would feel or care about. The bottom is a guess from software. Filled steps are where evidence exists for this substance.
- Living longer, or avoiding a major event Evidence recorded. Death, a heart attack, a stroke, a hospital stay.6 registered measures of this kind. No reviewed result.
- What a body can do day to day No evidence recorded. Walking, dressing, breathing, recovering.No registered study measures this.
- Measured performance No evidence recorded. How much was lifted, how far was run, how fast.No registered study measures this.
- Symptoms and quality of life No evidence recorded. Pain, tiredness, mood, sleep, as the person rated it.No registered study measures this.
- A number that stands in for health No evidence recorded. Cholesterol, blood sugar, bone density. A stand-in, not the thing itself.No registered study measures this.
- A step measured inside a person Evidence recorded. Something measured in human tissue or human cells.A human record sits on the stored organism ladder.
- Animals No evidence recorded. Mice, rats, dogs. Useful for ideas, not proof about people.No animal record is stored.
- Cells in a dish No evidence recorded. Cells or chemistry on a bench, far from a whole body.No cell or bench record is stored.
- A guess from software No evidence recorded. Nobody measured it. RNAWiki never publishes one as a finding.RNAWiki stores no prediction for this record. Software can suggest a link. RNAWiki does not publish one as a finding.
Higher on these steps means closer to something a person would feel. It does not mean better done.
What it would be like to takeRead from sources, not yet reviewed
Felt, measured, or meaningful
Three different things that get called the same word. Registered studies measured all three, and mixing them is how a blood test becomes a health claim.
Felt
Things a person could notice without a test.
No registered study measured anything of this kind.
Measured
Things only a test, a scale or a device shows.
No registered study measured anything of this kind.
Meaningful
Things that change how a life goes, not only a number.
- mortality
- hemorrhagic stroke
- stroke
- ischemic stroke
- all cause mortality
- stroke of any kind
A registered study says what someone planned to measure. It does not say what they found. A number moving is not the same as a life going better. The two are shown apart here.
Felt, but not shown to help. A person notices a change. No study showed it leads anywhere good.
Measured, but not felt. A number moves. The person notices nothing. Both can be true.
Measured, but not shown to matter. A number moves in the good direction. Nobody showed that lives went better.
Matters, but takes years. The result that counts may take longer than anyone would keep watching.
Names that fit none of the three (10)
- bleeding complications
- cumulative warfarin dose requirement by genotype category
- systemic embolism
- recurrent venous thromboembolism
- thromboembolic event
- primary safety endpoints
- optimal oac therapy
- venous thromboembolism
- primary efficacy endpoint
- primary safety endpoint
These are harms, study-process measures, or names the rules did not recognise. They are shown rather than dropped.
What is missing or unclearRead from sources, not yet reviewed
Were people like you studied?
RNAWiki cannot tell whether a study fits you. It can show who was in it, and where the result stops carrying.
Who was studied
People similar to this profile were included.
- For temporary relief of exhaustion & restlessness, metallic taste & dyspepsia & menstrual pain.
Who is missing from the studies
- Which groups were under-represented in the studies has not been recorded for this substance. Pregnancy, breastfeeding, children, older adults, and people with liver or kidney conditions are commonly excluded from trials; nothing here says whether they were.
Where the result stopped carrying
- This is a scope explorer, not a diagnosis engine.
- It shows who was studied so you can see whether people similar to you were included.
RNAWiki cannot tell whether a study fits you. It can show who was in it.
What it would be like to takeRead from sources, not yet reviewed
Why it might seem to do nothing
A real effect and a noticed effect are different things. These are the recorded reasons the two come apart.
The studies measured something else entirely.
On this record: Some registered studies measured things that match no goal on this page.
The people in the studies were not much like the reader.
On this record: Which groups were under-represented in the studies has not been recorded for this substance. Pregnancy, breastfeeding, children, older adults, and people with liver or kidney conditions are commonly excluded from trials; nothing here says whether they were.
Small early studies often do not hold up.
On this record: RNAWiki has not yet published a reviewed conclusion for this use.
Other reasons RNAWiki checked and found nothing for (10)
- A different form was studied
- The studied form is not the form on the shelf. Nothing in this record points to this reason.
- There was nothing to correct
- Where a level is already normal, topping it up may change nothing. Nothing in this record points to this reason.
- Something else had to happen too
- In the studies it was paired with training, a diet or another treatment. Nothing in this record points to this reason.
- The change is too small to feel
- A real change can still sit below what a person notices. Nothing in this record points to this reason.
- Day-to-day swing hides it
- Sleep, food, stress and time of day move most numbers more than this would. Nothing in this record points to this reason.
- Not enough time yet
- The studies ran longer than the person has waited. Nothing in this record points to this reason.
- It was not taken as studied
- Missed days change the result, and studies count them. Nothing in this record points to this reason.
- Something else changed at the same time
- Two changes at once cannot be told apart afterwards. Nothing in this record points to this reason.
- The product may not be what it says
- Contents of a sold product are not always what the label states. Nothing in this record points to this reason.
- No recorded reason
- RNAWiki has nothing stored that would explain it. Nothing in this record points to this reason.
None of these is a reason to take more. Taking more is not a step this page ever suggests.
What it would be like to takeRead from sources, not yet reviewed
What taking it involves
The recorded facts about getting hold of it and using it. Nothing here is a suggestion about what you should do.
How it is supplied
Varies by country
Quoted from a source
Where this came from
Copied from a source RNAWiki stored, with the source named.
Read from the recorded approval status.
No source is stored against this line.
Form and route
Oral
Source-linked record
Where this came from
A person wrote this into the record with the study named beside it. No reviewer has signed it off.
The form and route recorded on this substance.
No source is stored against this line.
Who oversees it
Not usually supervised: sold as a supplement or food ingredient where recorded. That is a legal category, not a safety judgement.
Quoted from a source
Where this came from
Copied from a source RNAWiki stored, with the source named.
The identity record classes it as a supplement ingredient; no medicines register records an approval.
No source is stored against this line.
What is in the pack
Sold as liquid, given by the oral route.
Source-linked record
Where this came from
A person wrote this into the record with the study named beside it. No reviewer has signed it off.
Recorded notes on how this is sold and what that means for what is in the pack.
No source is stored against this line.
Where it is registered
Regulatory records are listed in the technical disclosure at the foot of this page.
Counted from records
Where this came from
A count of rows RNAWiki holds. It describes our records, not your body.
Register entries are stored per jurisdiction and shown with their dates.
No source is stored against this line.
Why people stop
Not recorded.
Nothing recorded
Where this came from
RNAWiki holds nothing here and says so rather than guessing.
No record of why people stopped taking it is stored for this substance.
No source is stored against this line.
What it would be like to takeNothing found in the sources checked
What can go wrong
Sorted by where each line came from. A regulator's label and a report somebody sent in are not the same kind of fact.
Nothing found in the sources checked
No harm is recorded against this substance in the sources RNAWiki checked. Finding nothing is not the same as showing there is nothing.
The sources listed were searched and held nothing. That is not the same as nothing existing.
Over a long time. No completed tested study window is recorded, so long-term effects are not established by the registry record.
Groups the studies covered thinly. Which groups were under-represented in the studies has not been recorded for this substance. Pregnancy, breastfeeding, children, older adults, and people with liver or kidney conditions are commonly excluded from trials; nothing here says whether they were.
What is missing or unclearRead from sources, not yet reviewed
Does the exact form matter?
Evidence belongs to the exact thing that was tested. A different salt, a different mixture or a different preparation is a different question.
The form that was studied
Oral
Source-linked record
Where this came from
A person wrote this into the record with the study named beside it. No reviewer has signed it off.
The form used in the studies cited on this page.
No source is stored against this line.
What is sold
Not recorded.
Nothing recorded
Where this came from
RNAWiki holds nothing here and says so rather than guessing.
Nothing further is recorded about which forms are sold.
No source is stored against this line.
What is recorded as being sold
53 products list this as an active ingredient in the United States drug directory. 25 of them contain it and nothing else.
FDA National Drug Code directory · 0942-6320 · read 2026-08-29
They are sold as injection, solution, liquid, powder, powder, for solution, solution and tablet, chewable, taken extracorporeal, intravenous and oral.
FDA National Drug Code directory · 0942-6320 · read 2026-08-29
The regulator's established pharmacologic class for it is acidifying activity [moa], anti-coagulant [epc] and calcium chelating activity [moa].
FDA National Drug Code directory · 0942-6320 · read 2026-08-29
44 published labels name it as an active ingredient. 17 of them describe this substance alone, which is where its own label text on this page comes from.
US prescribing information · 0775912f-f14a-4967-ac00-c8c1b36040bf · read 2026-08-29
Those labels are classed as human otc drug and human prescription drug.
US prescribing information · 0775912f-f14a-4967-ac00-c8c1b36040bf · read 2026-08-29
742 marketed supplement labels list this ingredient, classed as mineral and non-nutrient/non-botanical.
NIH Dietary Supplement Label Database · 205966 · read 2026-08-29
Those labels carry all other, nutrient and structure/function claims. A claim of that kind is written by the manufacturer and is not assessed by any regulator, so its presence says nothing about whether it is true.
NIH Dietary Supplement Label Database · 205966 · read 2026-08-29
Sodium Citrate 4% w/v Anticoagulant is intravenous at 3 DOSAGE FORMS AND STRENGTHS 250 mL SODIUM CITRATE 4% W/V ANTICOAGULANT SOLUTION USP is a sterile solution in a PVC bag., recorded as fda label in effect 2025-01-23 in the United States.
US prescribing information · 0775912f-f14a-4967-ac00-c8c1b36040bf · read 2026-08-30
Evidence carries across two names for one substance. It does not carry across a salt, a mirror form or a mixture.
What it would be like to takeRead from sources, not yet reviewed
What you could measure
Watching one thing carefully can tell you whether it moved. It cannot tell you what moved it.
This is sold without a prescription, so a person can sensibly watch one thing and see whether it moves.
Pick one goal. One goal only. Two at once cannot be told apart afterwards.
Pick one thing to watch. No registered study lists a measure RNAWiki could read for this.
Measure before you start. Take the same measurement several times first. One reading is not a starting point.
Know the swing. Write down how much it moves on its own across a normal week.
Change one thing. Change nothing else at the same time, including training and sleep.
Give it the study length. No finished study window is recorded, so no length is suggested here.
Track whether you took it. Missed days are the most common reason a home test shows nothing.
Read the trend. Look at the line across weeks. A single reading tells you almost nothing.
What not to measure
- Anything that swings more day to day than the change you are looking for.
- A wearable estimate of sleep stages, which is an estimate and not a measurement.
- Weight on one morning, which mostly records water.
- A feeling you did not write down before starting.
When to stop
- Stop if something new and unpleasant starts, and ask a pharmacist or doctor.
- Stop if you cannot keep everything else steady, because the result will not mean anything.
- Stop at the end of the window you set, and read the trend then.
Tracking can show whether something changed for you. It cannot show what caused it.
RNAWiki does not work out an amount for anyone.
What is missing or unclearRead from sources, not yet reviewed
What nobody knows yet
Open questions, each with why it is open and what would close it.
How much did people take in the studies?
The sources RNAWiki checked hold nothing for this field.
Why it matters. A result belongs to an amount. Without the amount the result floats free.
What would answer it
A stored source that records it, and a reviewer to sign it off.
Last checked 2026-09-04. Searched: The sources listed in the receipts at the foot of this page.
How fast does the body clear it?
The sources RNAWiki checked hold nothing for this field.
Why it matters. Without this, nothing on this page can say how long anything lasts.
What would answer it
A stored source that records it, and a reviewer to sign it off.
Last checked 2026-09-04. Searched: The sources listed in the receipts at the foot of this page.
Missing populations
Which groups were under-represented in the studies has not been recorded.
Why it matters. Recorded by the evidence model as a gap on this record.
What would answer it
A study that measures it, and a reviewer to sign it off.
Last checked 2026-09-04. Searched: The sources listed in the receipts at the foot of this page.
Missing long-term data
No completed tested study window is recorded.
Why it matters. Recorded by the evidence model as a gap on this record.
What would answer it
A study that measures it, and a reviewer to sign it off.
Last checked 2026-09-04. Searched: The sources listed in the receipts at the foot of this page.
No reviewed conclusion
RNAWiki has not yet published a reviewed conclusion for this use.
Why it matters. Recorded by the evidence model as a gap on this record.
What would answer it
A study that measures it, and a reviewer to sign it off.
Last checked 2026-09-04. Searched: The sources listed in the receipts at the foot of this page.
Missing interaction studies
No interaction was found in the registers checked. Not finding one is not the same as showing there is none.
Why it matters. Recorded by the evidence model as a gap on this record.
What would answer it
A study that measures it, and a reviewer to sign it off.
Last checked 2026-09-04. Searched: The sources listed in the receipts at the foot of this page.
Formulation uncertainty
Several salts, forms or products of Anhydrous Trisodium are recorded. Results from one form may not transfer to another.
Why it matters. Recorded by the evidence model as a gap on this record.
What would answer it
A study that measures it, and a reviewer to sign it off.
Last checked 2026-09-04. Searched: The sources listed in the receipts at the foot of this page.
Mechanism not reviewed
No reviewed mechanism story exists for this substance.
Why it matters. Recorded by the evidence model as a gap on this record.
What would answer it
A study that measures it, and a reviewer to sign it off.
Last checked 2026-09-04. Searched: The sources listed in the receipts at the foot of this page.
What happened in peopleNothing found in the sources checked
Check any of this yourself
Every line above traced back to the study it came from. This is the technical layer, and the vocabulary changes here.
Nothing found in the sources checked
No traced study record is stored for this substance.
The sources listed were searched and held nothing. That is not the same as nothing existing.
Checks this page had to pass
Passed
Identity resolved
no open identity hold
Passed
No unresolved merge across substance families
no quarantine open
Passed
Every public sentence names a source
The opening statement carries the origin: Quoted from a stored source.
Not passed
Trial roles classified for highlighted evidence
No registered study is classified as testing this substance.
Passed
No internal keys in reader text
enforced by the copy-contract test over the rendered page
Passed
Safety mode resolved
The identity record classes it as a supplement ingredient; no medicines register records an approval.
Passed
Canonical metadata present
slug and display name present
What is missing or unclearRead from sources, not yet reviewed
How this medicine reached us
Kept near the foot of the page. A historical event moves up only when it changes something about this substance today.
What the approval register records
The earliest marketing start date recorded for a listed product is 19840515.
FDA National Drug Code directory · 0942-6320 · read 2026-08-29
What is missing or unclearRead from sources, not yet reviewed
What to learn next
Ordered by what would most change how you read this page, starting with what is easiest to misunderstand.
- Were people like me actually studied?
- How close is this evidence to something I would notice?
- What does nobody know about this yet?
- What is a biomarker?
This order is fixed in code and does not count clicks or time on the page.
What is not here
7 questions this page could not answer
These sections were prepared and left out because there was nothing to put in them. They are listed rather than hidden, so the gaps in this record are visible.
- What happened in people — found nothing in the sources checked.
- The path through the body — found nothing in the sources checked.
- How long anything takes — found nothing in the sources checked.
- What it may clash with — found nothing in the sources checked.
- Other ways to the same goal — found nothing in the sources checked.
- Claims that go past the evidence — found nothing in the sources checked.
- What changed on this page — found nothing in the sources checked.
The record as stored
The full record, for auditing
Everything above is built from what is below. This layer keeps the technical vocabulary, record identifiers and every stored row, so a reader who wants to check the page can.
Recorded evidence blocks (9)
What did Anhydrous Trisodium's largest trial (56272 people) and its longest (14 years) measure?
56272 people in Anhydrous Trisodium's largest registered study, 14 years in its longest registered window, measuring Mortality. ClinicalTrials.gov · 2026-09-01
14 na or unstated, 10 na, 7 phase4, 3 phase3, 1 phase1, 1 phase2; NCT07388056; 2025-12-31; no ageing endpoint recorded. Last human test completed 2026, NCT04907825.
Interpretation These counts include studies where Anhydrous Trisodium was a comparison treatment, a background treatment or an exposure in an observational study, and the longest window may be a planned end date. Trial roles have not yet been classified for this record.
Show the evidence
- na or unstated14
- na10
- phase47
- phase33
- phase11
- phase21
1 more recorded row
- Last recorded human test NCT049078252026-01-31
recorded 2026-09-01 · last checked 2026-09-04
Anhydrous Trisodium was tested only in human — what did it show?
human: lifespan (35): the rungs where Anhydrous Trisodium has a recorded finding. Europe PMC and ClinicalTrials.gov · organism ladder · 2026-09-01
Interpretation Mortality — the recorded outcome words.
Show the evidence
- human NCT01924065lifespan; Mortality; 35
recorded 2026-09-01 · last checked 2026-09-04
4 of Anhydrous Trisodium's trials stopped: futility/efficacy, accrual/recruitment, other?
futility/efficacy (1), accrual/recruitment (2) and other (1): Anhydrous Trisodium's stop wording, clustered. ClinicalTrials.gov · 2026-09-01
"Company suspended development of product."; 4 of 35 registered studies
Show the evidence
Trial
- NCT00443573suspended; "Company suspended development of product."
- NCT00680459terminated; "inability to enroll adequate number of patients"
- NCT00726570terminated; "Failed to reach the expected enrollment rates by the end of 2010"
- NCT03062319terminated; "The trial was terminated at the planned interim analysis for futility on July 18, 2023."
recorded 2026-09-01 · last checked 2026-09-04
Could one person measure Anhydrous Trisodium's effect on bleeding complications?
Bleeding complications: measured in Anhydrous Trisodium's trials.
Interpretation bleeding complications is the recorded endpoint.
Show the evidence
biomarkers
- bleeding complications; 2026-09-01
- cumulative warfarin dose requirement by genotype category; 2026-09-01
- mortality; 2026-09-01
- hemorrhagic stroke; 2026-09-01
- stroke; 2026-09-01
- systemic embolism; 2026-09-01
10 more recorded rows
- biomarkersrecurrent venous thromboembolism; 2026-09-01
- biomarkersthromboembolic event; 2026-09-01
- biomarkersischemic stroke; 2026-09-01
- biomarkersprimary safety endpoints; 2026-09-01
- biomarkersall cause mortality; 2026-09-01
- biomarkersstroke of any kind; 2026-09-01
- biomarkersoptimal oac therapy; 2026-09-01
- biomarkersvenous thromboembolism; 2026-09-01
- biomarkersprimary efficacy endpoint; 2026-09-01
- biomarkersprimary safety endpoint; 2026-09-01
- human trials at or under304
- Not recorded for this substancea recorded half-life
- smallest human trial1; NCT03904329; NA_OR_UNSTATED; the smallest recorded human enrolment at or below 30; the registry states no direction of its result; UNKNOWN
Which of all cause mortality, bleeding complications and cumulative warfarin dose requirement by genotype category did Anhydrous Trisodium's trials measure?
all cause mortality, bleeding complications and cumulative warfarin dose requirement by genotype category lead 16 outcome terms across Anhydrous Trisodium's trials. ClinicalTrials.gov · 2026-09-01
Interpretation hemorrhagic stroke, stroke, systemic embolism, recurrent venous thromboembolism, thromboembolic event and ischemic stroke follow.
Show the evidence
- bleeding complications1
- cumulative warfarin dose requirement by genotype category1
- mortality1
- hemorrhagic stroke1
- stroke1
- systemic embolism1
10 more recorded rows
- recurrent venous thromboembolism1
- thromboembolic event1
- ischemic stroke1
- primary safety endpoints1
- all cause mortality1
- stroke of any kind1
- optimal oac therapy1
- venous thromboembolism1
- primary efficacy endpoint1
- primary safety endpoint1
recorded 2026-09-01 · last checked 2026-09-04
Which of Anhydrous Trisodium's 8 ongoing trials reports first?
8 registered trials of Anhydrous Trisodium are open; earliest completion 2026-08-31. ClinicalTrials.gov · 2026-09-01
Change in LH Pulse Amplitude Before and After Acute or Chronic FFA Administration; Composite Outcome: Number of Participants with Major Bleeding and Recurrent VTE; latest 2028-12-31
Show the evidence
Trial
- NCT02653092"Reprometabolic Syndrome Mediates Subfertility in Obesity"; n 84; "Change in LH Pulse Amplitude Before and After Acute or Chronic FFA Administration"; 2026-12-11
- NCT04660747"Direct Oral Anticoagulants for the Treatment of Cerebral Venous Thrombosis"; n 1300; "Composite Outcome: Number of Participants with Major Bleeding and Recurrent VTE"; 2028-01
- NCT04694248"Anticoagulant Plus Antiplatelet Therapy Following Iliac Vein Stenting"; n 172; "Primary Effectiveness Endpoints"; 2027-06-30
- NCT04847752"Study of Predictive Factors Related to Prognosis of Patients With Ischemic Stroke Due to Large-artery Atherosclerosis"; n 1000; "all-cause mortality"; 2028-12-31
- NCT06284343"The Gynecological Cancer Associated Thrombosis (GynCAT) Study"; n 1800; "Number of Participants with Venous thromboembolism"; 2026-09-30
- NCT06402851"Vitamin K AntagonISt, Factor Xa Inhibitor or No Anticoagulation in Atrial Fibrillation and DIalytic End-stage Renal DiseasE (VISIONAIRE)"; n 1500; "Primary efficacy endpoint"; 2026-12
2 further recorded trials
- NCT07559942"Effect of Apiban Therapy on AVF Maturation in ESRD Patients"; n 190; "AV Fistula Maturation"; 2026-08-31
- NCT07737327"The Effect of Individual Sodium Citrate Consumption on Repeated Sprint Performance in Female Soccer Players"; n 20; "Minimum Power"; 2027-02-01
recorded 2026-09-01 · last checked 2026-09-04
Which running trial of Anhydrous Trisodium could settle lifespan?
NCT04847752 measures all-cause mortality, reading out 2028-12-31.
1 open trial; n 1000; "Study of Predictive Factors Related to Prognosis of Patients With Ischemic Stroke Due to Large-artery Atherosclerosis"
Show the evidence
- Trial NCT04847752"Study of Predictive Factors Related to Prognosis of Patients With Ischemic Stroke Due to Large-artery Atherosclerosis"; n 1000; "all-cause mortality"; 2028-12-31
Which 10 trials of Anhydrous Trisodium posted no result?
- Posted no result
- 10 of 10 completed trials
- Registrations
- NCT00966290, NCT00286273, NCT01689753, NCT00238667, NCT02734875 and NCT04554979, and 4 more
- Completion dates
- oldest 2006-12; newest 2022-08
Show the evidence
Trial
- NCT009662902006-12
- NCT002862732008-03
- NCT016897532011-03
- NCT002386672014-05
- NCT027348752017-08
- NCT045549792020-07-15
4 further recorded trials
- NCT040992382020-07-16
- NCT042335152021-01-29
- NCT032926662022-06-21
- NCT063750702022-08
At the median, Anhydrous Trisodium's trials enrolled 246 people — anything larger?
- Median enrolment
- 246
- Largest enrolment
- 56272
- Registered trials counted
- 35
Where it is registered
Identifiers, relations and other names
- Salt form
- Anhydrous Trisodium Citrate, ANTICOAGULANT SODIUM CITRATE, Sodium Citrate w/v Anticoagulant, SODIUM CITRATE, SODIUM CITRATE DIHYDRATE, TRISODIUM CITRATE DIHYDRATE, ANTICOAGULANT SODIUM CITRATE SOLUTION, Sodium Citrate 4% w/v Anticoagulant, Sodium Citrate Blood-Pack Units, (PL 146 Plastic)
- Trade name
- Lipotox, Nauzene, triCitrasol, Emetrol Chewables, Emetrol Chewables Orange, Emetrol Powder Non-Drowsy, CVS Health Nausea Relief, Emetrol Chewables Mixed Berry, Nauzene Chewables Ginger Honey, QUALITY CHOICE Nausea Relief, WALGREENS UPSET STOMACH and NAUSEA RELIEF
Sources (4)
Sources
- ClinicalTrials.gov ClinicalTrials.gov API v2 snapshot 2026-09-01T09:00:05 ·
- this record's own fields 2,3,5 ·
- Europe PMC and ClinicalTrials.gov organism ladder ·
- national registers US, CA ·
ClinicalTrials.gov — US Government work · Europe PMC — metadata only, under the recorded legal gate · derived from this page's own recorded fields; no external licence · mixed register set; per-register licences in docs/specs/corpus-20k-sources.md
How these records are assembled · Which registers were checked
Index-quality checks
- identity passed: no open identity hold
- required summary fields resolved: 4 required field(s) not terminal: Why people use it, Best-supported result, Biggest unanswered question, Human evidence
- public claims reviewed: 0 reviewed claim(s); drafts are never rendered
- source coverage passed: 4 source rows
- no critical contamination: no quarantine open
- canonical metadata passed: slug and display name present
- no raw internal fields: enforced by the copy-contract test over the rendered page
This is a record of evidence. It is not medical advice, and it does not say this substance suits you. Nothing here says any substance on RNAWiki is appropriate for a child.